aim
aim
studi
verifi
suitabl
use
candid
probiot
select
vitro
test
import
vivo
assay
nomin
microorgan
probiot
altern
prophylact
treatment
salmonella
typhimurium
infect
method
result
thirtythre
lactic
acid
bacteria
lab
isol
foal
faec
assess
base
main
desir
function
vitro
criteria
base
result
pediococcu
pentosaceu
strain
chosen
evalu
put
probiot
featur
mous
model
salmonella
infect
daili
intragastr
dose
ped
pentosaceu
day
day
salmonella
challeng
cfu
salm
typhimurium
per
mous
led
signific
aggrav
mous
health
increas
weight
loss
worsen
clinic
symptom
anticip
time
number
death
salmonella
pediococcu
pentosaceu
modul
cellmedi
immun
respons
upregul
gene
express
proinflammatori
cytokin
ifnc
tnfa
small
intestin
conclus
usual
criteria
use
vitro
screen
larg
number
lab
desir
probiot
function
properti
howev
best
candid
probiot
strain
identifi
ped
pentosaceu
aggrav
experiment
diseas
mice
signific
impact
studi
find
emphas
need
prophylact
therapeut
effect
demonstr
vivo
model
make
precis
health
claim
probioticsl
microorgan
administ
adequ
amount
confer
health
benefit
host
faowho
hill
et
al
receiv
special
attent
farmer
seek
altern
use
tradit
antibiot
growth
promot
alreadi
shown
immunomodul
sever
probiot
kept
host
immun
system
prime
respond
faster
effect
microbi
infect
fagund
et
al
numer
studi
propos
use
probiot
improv
gut
health
treatment
inflammatori
bowel
diseas
heselman
et
al
chave
et
al
prevent
antibioticinduc
diarrhoea
song
et
al
one
foremost
alleg
studi
regard
abil
probiot
protect
sever
infecti
agent
especi
enteropathogen
cremonini
et
al
maragkoudaki
et
al
protect
effect
certain
probiot
strain
specif
pathogen
undeni
howev
scientif
basi
mean
probiot
confer
protect
must
well
establish
great
number
protect
mechan
propos
protect
studi
stabil
gut
mucos
barrier
yan
et
al
stimul
mucu
secret
goblet
cell
dogi
perdig
ohland
macnaughton
competit
nutrient
secret
antimicrobi
substanc
bacteriocin
modul
mucos
system
immun
respons
lebeer
et
al
castillo
et
al
lactic
acid
bacteria
lab
acquir
gener
recogn
safe
statu
long
histori
use
food
supplement
agent
ferment
natur
product
starter
cultur
probiot
franz
et
al
anim
benefici
gut
bacteria
interact
activ
microorgan
belong
indigen
microbiota
transient
pathogen
inhibit
instal
exogen
uncontrol
multipl
commens
fagund
et
al
demonstr
probiot
replac
convent
growth
promot
antibiot
especi
newborn
anim
jouani
morgavi
castillo
et
al
new
commens
bacteria
consist
defin
strain
food
human
anim
sourc
adequ
evid
safeti
efficaci
host
health
socal
probiot
hill
et
al
select
criteria
new
strain
applic
probiot
involv
vitro
test
adequ
gastrointestin
transit
antimicrobi
activ
microbi
pathogen
suscept
antimicrobi
agent
surviv
process
storag
silva
et
al
subsequ
promis
strain
test
vitro
undergo
subsequ
vivo
challeng
howev
doubt
persist
regard
real
valu
vitro
select
criteria
microorgan
use
healthpromot
agent
critic
rethink
select
criteria
seem
necessari
improv
process
develop
better
probiot
morelli
criteria
includ
function
characterist
abil
resist
environment
condit
found
digest
tract
low
gastric
ph
bile
salt
abil
antagon
competit
exclud
pathogen
via
secret
antimicrobi
substanc
competit
nutrient
epitheli
adhes
site
lactic
acid
bacteria
produc
differ
antimicrobi
compon
organ
acid
hydrogen
peroxid
carbon
peroxid
diacetyl
low
molecular
weight
antimicrobi
substanc
bacteriocin
adhes
inhibitor
servin
ripamonti
et
al
adhes
lab
involv
passiv
forc
electrostat
interact
hydrophob
steric
forc
lipoteico
acid
lectin
servin
hydrophob
natur
outermost
surfac
microorgan
facilit
adhes
bacteria
host
epithelium
therebi
confer
competit
advantag
colon
gastrointestin
tract
vinderola
reinheim
antimicrobi
suscept
intestin
microorgan
import
criterion
select
probiot
strain
like
possibl
later
gene
transfer
potenti
pathogen
commens
bacteria
inhabit
gastrointestin
tract
mathur
singh
ripamonti
et
al
sever
scientif
evidencebas
indic
probiot
prevent
treat
gastroenterolog
disord
indic
reli
specif
strain
optim
dosag
mechan
action
song
et
al
tsai
et
al
ringel
et
al
alvim
et
al
unfortun
mani
socal
probiot
properli
prove
veterinari
medic
practic
yet
variou
produc
make
gener
health
claim
lead
consum
believ
use
safe
reliabl
efficaci
product
howev
gener
prophylact
use
probiot
consum
function
food
dietari
supplement
could
establish
scenario
host
favour
initi
infect
spread
pathogen
could
occur
result
chang
healthi
microbiota
lead
associ
diseas
also
alter
local
system
immunolog
statu
host
reid
et
al
probiot
product
appli
hors
gener
compris
live
bacteri
cultur
intend
use
prevent
undesir
consequ
stress
due
failur
ingest
colostrum
wean
switch
feed
transport
advers
weather
diseas
recurr
nutrit
debilit
prolong
antibiot
therapi
mont
pugh
work
lab
strain
isol
stool
sampl
young
hors
select
new
probiot
pediococcu
pentosaceu
strain
promis
vitrotest
strain
chosen
subsequ
vivo
challeng
mous
model
salmonella
infect
faec
two
suckl
foal
two
foal
hay
feed
mangalarga
machador
breed
individu
process
use
studi
anim
treat
type
medic
isol
lab
assess
function
properti
faecal
specimen
homogen
use
glass
rod
steril
tube
contain
salin
serial
salin
dilut
plate
onto
de
man
rogosa
sharp
mr
agar
difco
bd
bioscienc
franklin
lake
nj
incub
h
anaerob
chamber
forma
scientif
inc
marietta
oh
contain
atmospher
n
h
co
distinct
coloni
select
process
gram
stain
bacteri
morpholog
examin
gramposit
bacteria
bacillu
coccobacillu
morpholog
assay
catalas
activ
neg
consid
probabl
lab
isol
regularli
cultur
inocul
mr
broth
vv
fresh
stationari
cultur
incub
anaerob
condit
h
lactobacillu
isol
identifi
speci
level
rrna
ardra
amplifi
ribosom
dna
restrict
analysi
necessari
lab
isol
identifi
rrna
gene
sequenc
report
sand
et
al
bacteri
lineag
cluster
reppcr
repetit
extragen
polymorphicbas
polymeras
chain
reaction
fingerprint
use
gtg
primer
gtg
gtg
gtg
gtg
accord
versalov
et
al
potenti
probiot
microorgan
fulfil
sever
select
criteria
includ
autochthon
origin
gastric
acid
intestin
bile
toler
abil
adher
epitheli
tissu
product
substanc
antagon
pathogen
avoid
infect
well
nonpathogen
nontoxigen
noninvas
devoid
transmiss
antibiot
resist
gene
resist
technolog
process
transient
persist
gastrointestin
tract
abl
modul
host
immun
respons
influenc
microbiota
balanc
posit
lahteenmaki
ledebo
select
criteria
compris
cell
surfac
hydrophob
antagonist
activ
bacteri
pathogen
microbi
suscept
antibiot
artifici
gastric
juic
bile
salt
suscept
appli
accord
methodolog
describ
silva
et
al
cell
surfac
hydrophob
assess
microbi
adhes
solvent
mat
approach
lab
cultur
stationari
phase
centrifug
wash
twice
pb
adjust
od
nm
mol
l
kno
ph
next
xylen
ad
bacteri
suspens
form
twophas
system
aqueou
phase
remov
od
nm
measur
mat
calcul
percentag
lab
associ
xylen
accord
formula
adhes
capabl
lab
strain
indirectli
assess
mat
instead
use
intestin
epitheli
cell
obtain
anim
small
intestin
prefer
prospect
studi
mani
bacteri
isol
less
timeconsum
less
expens
five
microlitr
lab
cultur
stationari
phase
spot
onto
mr
agar
incub
anaerob
condit
h
next
cell
kill
exposur
chloroform
vapour
min
brain
heart
infus
bhi
acumedia
neogen
corp
lans
mi
six
pathogen
bacteria
listeria
monocytogen
atcc
staphylococcu
aureu
atcc
enterococcu
faecali
atcc
escherichia
coli
atcc
salmonella
enterica
atcc
pseudomona
aeruginosa
atcc
cultur
stationari
phase
microorgan
inocul
bhi
soft
agar
use
overlay
surfac
mr
plate
contain
dead
lab
incub
h
lab
antagonist
activ
determin
measur
growth
inhibit
zone
use
digit
pachymet
mitutoyo
sul
americana
ltd
paulo
brazil
antibiogram
creat
lab
strain
disc
diffus
method
bacteri
suspens
adjust
viabl
cell
accord
mcfarland
nephelometr
scale
next
strain
spread
onto
mr
agar
antibiot
disc
amikacin
lg
ampicillin
lg
ceftriaxon
lg
chloramphenicol
lg
erythromycin
lg
oxacillin
lg
penicillin
g
u
vancomycin
lg
oxoid
ltd
basingstok
uk
dispens
onto
surfac
use
antibiot
disc
dispens
incub
h
inhibit
zone
around
disc
measur
use
digit
pachymet
mitutoyo
sul
americana
ltd
lab
strain
qualit
classifi
resist
sensit
moder
sensit
strain
accord
cutoff
level
propos
charteri
et
al
gastric
juic
suscept
gj
bile
salt
suscept
bss
assess
take
account
interfer
growth
rate
perform
faecal
strain
gj
lab
strain
stationari
phase
suspend
either
pb
artifici
gastric
juic
g
l
nacl
pepsin
g
l
ph
incub
h
sampl
centrifug
pellet
suspend
mr
broth
bss
lab
strain
stationari
phase
centrifug
suspend
either
mr
broth
mr
broth
supplement
ox
gall
oxoid
ltd
bacteri
suspens
aliquot
steril
microwel
plate
incub
h
thermoregul
spectrophotomet
micropl
spectrophotomet
system
spectramax
molecular
devic
sunnyval
ca
od
nm
measur
min
interv
gj
bss
calcul
accord
formula
area
ct
area
area
ct
growth
curv
stress
strain
artifici
gastric
juic
bile
salt
control
cell
pb
respect
bacteri
strain
cultur
condit
ped
pentosaceu
isol
henceforth
refer
chosen
vitro
screen
desir
physiolog
properti
salm
enterica
serovar
typhimurium
strain
kindli
provid
fundac
ezequiel
dia
fune
belo
horizont
mg
brazil
due
dissimilar
level
virul
andor
invas
mice
differ
strain
salm
typhimurium
wellcharacter
strain
chosen
laboratori
alreadi
use
sever
work
publish
year
infect
kill
mice
low
dose
silva
et
al
martin
et
al
bacteria
store
mr
bhi
broth
accumedia
neogen
corp
lans
mi
glycerol
reactiv
cultur
grown
h
aerob
condit
work
use
surviv
evalu
rel
cytokineencod
gene
mrna
express
balbc
mice
sex
tacon
germantown
ny
water
commerci
autoclav
diet
nuvit
curitiba
pr
brazil
steril
steam
administ
ad
libitum
anim
hous
plastic
miniisol
ventil
rack
alesco
paulo
brazil
maintain
anim
hous
control
light
h
lightdark
cycl
temperatur
handl
accord
standard
outlin
guid
care
use
laboratori
anim
nation
research
council
institut
ethic
committe
anim
experiment
ceteaufmg
approv
experi
agreement
number
assay
evalu
effect
treatment
ped
pentosaceu
morbid
mortal
experiment
bacteri
challeng
perform
use
two
group
mice
mice
pretreat
strain
day
cfu
daili
ml
intragastr
gavag
steril
salin
challeng
salm
typhimurium
cfu
singl
dose
ml
intragastr
gavag
weigh
death
event
record
day
infect
assay
evalu
effect
treatment
ped
pentosaceu
liver
histolog
analysi
experiment
bacteri
challeng
perform
use
four
group
mice
pretreat
strain
day
cfu
daili
ml
intragastr
gavag
steril
salin
challeng
salm
typhimurium
cfu
singl
dose
ml
intragastr
gavag
mice
euthan
day
salmonella
challeng
day
tissu
sampl
excis
highest
lobe
liver
sampl
fix
embed
paraffin
wax
lm
thick
tissu
section
cut
stain
haematoxylin
eosin
singl
pathologist
blind
experiment
condit
evalu
overal
architectur
liver
numer
valu
attribut
chang
observ
liver
anim
receiv
score
valu
describ
mathur
et
al
liver
tissu
evalu
follow
paramet
chang
hepatocyt
tissu
architectur
normal
cellular
presenc
discret
inflammatori
foci
maximum
field
associ
lamina
propria
vessel
congest
inflammatori
foci
per
field
associ
discret
hepatocyt
chang
inflammatori
foci
number
per
field
moder
degen
chang
hepatocyt
vacuol
foci
inflammatori
infiltr
coalesc
associ
sever
degen
chang
hepatocyt
intens
intracellular
vacuol
result
express
median
standard
deviat
score
rel
express
mrna
cytokineencod
gene
day
ingest
ped
pentosaceu
n
untreat
control
n
mice
anaesthet
euthan
cervic
disloc
fragment
measur
cm
length
obtain
section
small
intestin
proxim
middl
distal
anim
intestin
content
remov
fragment
store
rnalat
ambion
austin
tx
frozen
subsequ
extract
total
rna
total
rna
isol
use
trizol
life
technolog
corp
grand
island
ny
accord
manufactur
instruct
genom
dna
remov
use
turbo
dnase
revers
transcript
perform
use
high
capac
cdna
revers
transcript
accord
manufactur
instruct
life
technolog
carlsbad
ca
rel
quantif
mrna
level
gene
encod
cytokin
ifnc
forward
primer
tcaagtggcata
revers
primer
tggct
tnfa
forward
primer
revers
primer
forward
primer
gaggataccactcccaacagac
revers
primer
forward
primer
ggttgccaa
revers
primer
acctgctcc
tgfb
forward
primer
tg
revers
primer
g
perform
accord
ing
steinberg
et
al
genespecif
primer
refer
gene
actb
forward
primer
agagggaaat
revers
primer
caatagtgatg
gapdh
forward
primer
tcac
revers
primer
gctaag
sigmaaldrich
st
loui
mo
use
normal
express
data
accord
method
giulietti
et
al
express
level
noninfect
control
group
use
calibr
data
rel
level
mrna
rlmrna
cytokin
obtain
method
rel
deriv
quantif
describ
helleman
et
al
result
express
graphic
use
mean
standard
deviat
rlmrna
cytokin
normal
refer
gene
express
level
shapirowilk
test
normal
statist
use
determin
data
distribut
oneway
analysi
varianc
anova
follow
tukeykram
test
twoway
anova
follow
bonferroni
posttest
use
parametr
sampl
kruskalw
test
follow
dunn
test
use
compar
nonparametr
sampl
longrank
test
perform
surviv
evalu
test
data
consid
significantli
differ
p
thirtythre
lab
isol
obtain
foal
faecal
sampl
confirm
gramposit
nonsporul
catalaseneg
divers
rang
size
molecular
character
isol
speci
level
conduct
pcrardra
could
identifi
two
lactobacillu
speci
lactobacillu
reuteri
lactobacillu
crispatu
one
weissella
speci
weissella
confusa
speci
ped
pentosaceu
lactobacillu
equi
enterococcu
casseliflavu
identifi
rrna
sequenc
analysi
lab
speci
identifi
follow
descend
order
abund
w
confusa
ped
pentosaceu
e
casselifavu
lact
reuteri
lact
crispatu
lact
equi
tabl
fig
weissella
confusa
frequent
isol
speci
equin
faec
eighteen
strain
found
gtg
pcr
profil
fig
vitro
assess
function
properti
isol
obtain
work
perform
base
follow
criteria
artifici
gastric
juic
bile
salt
toler
cell
surfac
hydrophob
antagonist
activ
pathogen
antibiot
resist
pattern
tabl
summar
characterist
isol
almost
isol
highli
resist
acid
ph
littl
less
decreas
viabl
cell
number
h
incub
ph
remain
isol
found
toler
acid
ph
tabl
contrast
sensit
bile
salt
vari
markedli
strain
differ
speci
tabl
five
strain
show
littl
growth
inhibit
mr
broth
supplement
ox
gall
inhibit
consid
resist
anoth
five
strain
moder
toler
bile
salt
inhibit
wherea
remain
nine
strain
suscept
inhibit
mat
method
use
evalu
hydrophobichydrophil
cell
surfac
properti
lab
isol
comparison
probiot
bacteria
bacteri
adhes
xylen
high
ionic
strength
mol
l
ph
reflect
cell
surfac
hydrophob
hydrophil
electrostat
interact
absent
result
indic
three
lab
isol
highli
hydrophob
surfac
adhes
strain
consid
moder
hydrophob
adhes
remain
three
strain
hydrophil
surfac
adhes
tabl
inhibitori
capac
pathogen
evalu
use
vitro
antagon
test
result
show
divers
antagonist
activ
six
bacteri
pathogen
test
salm
enterica
serovar
typhimurium
e
coli
ps
aeruginosa
staph
aureu
ent
faecali
l
monocytogen
isol
hors
faec
show
antagon
pathogen
w
confusa
strain
ped
pentosaceu
strain
lact
equi
strain
tabl
studi
lab
isol
show
antagonist
activ
toward
salm
enterica
serovar
typhimurium
lab
isol
evalu
resist
antibiot
accord
cutoff
valu
propos
charteri
et
al
strain
consid
resist
inhibit
zone
diamet
equal
smaller
mm
oxacillin
ampicillin
penicillin
g
mm
amikacin
vancomycin
tetracyclin
mm
ceftriaxon
chloramphenicol
erythromycin
isol
exhibit
antimicrobi
suscept
pattern
resist
vancomycin
oxacillin
amikacin
sensit
erythromycin
penicillin
ceftriaxon
ampicillin
tetracyclin
chloramphenicol
tabl
analys
function
characterist
ped
pentosaceu
strain
show
inhibit
acid
ph
low
inhibit
bile
salt
hydrophob
cell
surfac
strong
antagon
bacteri
gramneg
gramposit
pathogen
antimicrobi
resist
intrins
encod
vancomycin
oxacillin
amikacin
associ
mobil
genet
element
tabl
thu
ped
pentosaceu
strain
select
test
vivo
mous
model
salmonella
infect
higher
surviv
rate
salm
typhimuriuminfect
mice
observ
control
anim
compar
anim
postchalleng
day
surviv
respect
n
mice
per
group
well
delay
day
begin
anim
death
fig
find
replic
three
independ
experi
also
test
two
put
strain
w
confusa
lact
equi
surviv
rate
observ
data
shown
concern
safeti
ped
pentosaceu
strain
perform
liver
histopatholog
score
analysi
observ
group
mice
receiv
bacteria
gavag
show
signific
differ
control
group
mice
receiv
salin
ae
ped
pentosaceu
group
ae
untreat
group
otherwis
challeng
mice
group
treat
ped
pentosaceu
treat
show
signific
increas
histopatholog
score
valu
compar
nonchalleng
group
ae
ped
pentosaceu
group
ae
untreat
group
investig
whether
ped
pentosaceu
could
induc
cytokin
express
vivo
balbc
mice
administ
bacteria
intragastr
day
rel
quantif
mrna
level
tnfa
ifnc
tgfb
intestin
tract
mice
treat
ped
pentosaceu
shown
fig
treatment
ped
pentosaceu
reveal
inflammatori
profil
induc
signific
increas
product
ifnc
throughout
experi
tnfa
day
p
tgfb
cytokin
analys
signific
differ
experiment
group
fig
amplifi
ribosom
dna
restrict
analysi
effici
method
specieslevel
identif
among
lactobacillu
speci
stoyancheva
et
al
sand
et
al
base
presenc
polymorph
intern
transcrib
spacer
rrna
gene
show
lactobacillu
speci
display
uniqu
restrict
pattern
method
therefor
could
precis
identifi
amplif
could
establish
three
group
lab
genera
streptococcuslactococcu
one
amplicon
enterococcu
two
amplicon
differ
size
lactobacillusweissella
pediococcu
three
amplicon
differ
size
studi
ardra
use
identifi
lab
isol
faec
young
foal
lab
isol
three
amplicon
belong
lactobacillusweissella
pediococcu
group
wherea
three
two
amplicon
belong
enterococcu
group
weissella
confusa
preval
speci
account
lab
isol
result
agre
find
endo
et
al
w
confusa
one
preval
pathogen
hors
faec
addit
lact
equi
lact
reuteri
lact
crispatu
previous
detect
faec
hors
author
morotomi
et
al
endo
et
al
endo
et
al
speci
lact
equi
accord
literatur
date
consid
exclus
equin
speci
morotomi
et
al
among
genu
pediococcu
pediococcu
denticolen
previous
isol
faec
hors
endo
et
al
pediococcu
pentosaceu
yet
isol
hors
faec
speci
genu
enterococcu
faec
hors
describ
niederhausern
et
al
includ
strain
ent
casseliflavu
like
found
studi
possibl
bacteri
isol
anim
clonal
relat
verifi
genom
fingerprint
use
repetit
element
sequencebas
polymeras
chain
reaction
reppcr
gtg
primer
analysi
employ
oligonucleotid
primer
target
repetit
dna
element
distribut
throughout
bacteri
genom
versalov
et
al
element
contain
conserv
region
allow
primer
hybrid
target
sequenc
stringent
condit
stephenson
et
al
markiewicz
et
al
lee
et
al
reppcr
fingerprint
techniqu
use
gtg
pcr
rapid
easytoperform
reproduc
tool
differenti
wide
rang
lactobacilli
speci
subspeci
potenti
strain
level
gever
et
al
lee
et
al
bacteria
isol
ident
gtg
pattern
consid
strain
distinct
profil
observ
screen
cell
viabil
probabl
fundament
test
efficaci
lab
probiot
vehicl
oral
deliveri
benefici
protein
thu
import
characterist
new
probiot
strain
abil
resist
acid
bile
guo
et
al
ripamonti
et
al
ph
stomach
hors
rang
ingest
feed
persist
approxim
h
stomach
anim
voro
botha
wees
et
al
test
feasibl
use
lab
probiot
healthi
hors
report
surviv
rate
approxim
bacteri
incub
ph
h
surviv
rate
consid
adequ
isol
consid
acidtoler
isol
current
studi
show
percentag
inhibit
ph
h
rate
inhibit
could
also
consid
adequ
find
agre
author
found
bacteria
intestin
origin
tend
resist
stomach
acid
morelli
resist
bile
salt
also
import
paramet
select
probiot
strain
bile
secret
small
intestin
reduc
surviv
bacteria
destroy
cell
membran
toxic
effect
bile
bacteri
cell
well
understood
bile
salt
surfaceact
amphipath
molecul
potent
antimicrobi
activ
act
deterg
disrupt
biolog
membran
lebeer
et
al
mean
bile
concentr
small
intestin
wv
use
select
new
probiot
strain
mainvil
et
al
percentag
resist
bile
salt
also
tend
vari
among
lab
even
strain
speci
mirlohi
et
al
silva
et
al
equin
bile
continu
releas
small
intestin
hors
biliari
vesicl
gastrointestin
tract
botha
consid
isol
resist
exhibit
inhibit
rate
toler
inhibit
rate
rang
sensit
inhibit
rate
wees
et
al
challeng
equin
lab
bile
salt
h
report
major
isol
inhibit
wherea
remain
isol
higher
inhibit
consid
isol
toler
bile
salt
bacteri
cell
hydrophob
directli
relat
abil
strain
adher
surfac
abil
determin
hydrophob
compon
present
outer
membran
microorgan
known
interact
play
import
role
adhes
bacteria
epithelium
guo
et
al
test
adhes
solvent
mat
facilit
qualit
assess
polar
nonpolar
bacteri
surfac
import
indic
potenti
probiot
adhes
apolar
surfac
mucos
epithelia
howev
test
primari
indic
adher
microorgan
guo
et
al
result
mat
lab
strain
show
isol
exhibit
high
hydrophob
botha
test
four
strain
lab
isol
hors
one
show
hydrophob
consid
medium
hydrophob
surfac
other
low
hydrophob
present
studi
agar
spot
assay
use
initi
determin
antagonist
activ
via
diffus
compound
produc
lab
test
indic
activ
variou
gramposit
gramneg
bacteria
inhibitori
effect
might
due
h
lactic
acid
bacteriocin
antibioticlik
substanc
combin
compound
nardi
et
al
five
isol
show
antagonist
activ
six
bacteri
pathogen
salmonella
infect
common
caus
acut
diarrhoea
foal
zoonot
potenti
mastroeni
grant
therefor
import
pathogen
antagon
candid
probiot
studi
isol
equin
faec
show
antagonist
activ
toward
salm
enterica
serovar
typhimurium
atcc
consist
literatur
claim
bacteria
produc
lactic
acid
would
suffici
inhibit
growth
pathogen
wees
et
al
addit
wees
et
al
report
lactic
acid
could
increas
permeabl
outer
membran
gramneg
microorgan
thu
inhibit
cellular
function
microorgan
howev
studi
test
vitro
inhibitori
activ
isol
salmonella
attc
includ
ped
pentosaceu
applic
strain
use
vivo
assay
present
studi
also
found
isol
exhibit
antagonist
activ
ent
faecali
anoth
lab
find
suggest
substanc
lactic
acid
act
antagonist
lactic
acid
bacteria
wide
use
probiot
starter
cultur
potenti
host
antibiot
resist
gene
thu
present
risk
transfer
gene
mani
lab
pathogen
bacteria
mathur
singh
plasmidlink
antibiot
resist
common
among
lab
occur
safeti
implic
consid
strain
harbour
resist
plasmid
use
human
anim
probiot
assess
capac
propos
probiot
strain
act
donor
conjug
antibiot
resist
gene
could
sensibl
precaut
instanc
ripamonti
et
al
knowledg
intrins
code
resist
lab
common
antibiot
necessari
recogn
acquir
resist
trait
isol
exhibit
antimicrobi
suscept
pattern
resist
vancomycin
oxacillin
amikacin
sensit
erythromycin
penicillin
ceftriaxon
ampicillin
microorgan
belong
genera
lab
enterococcu
leuconostoc
pediococcu
weissella
emphas
intrins
resist
vancomycin
wright
mathur
singh
result
consist
numer
studi
often
report
high
degre
resist
lab
antibiot
class
glycopeptid
vancomycin
aminoglycosid
amikacin
oxacillin
bywat
ammor
et
al
strain
analys
suscept
ampicillin
ceftriaxon
chloramphenicol
erythromycin
lactic
acid
bacteria
sensit
antibiot
commonli
report
scientif
articl
klare
et
al
danielsen
wind
report
high
sensit
lab
presenc
inhibitor
cell
wall
synthesi
ampicillin
penicillin
consider
physiolog
vitrospecif
strain
use
effici
method
preliminari
select
probiot
bacteria
morelli
food
agricultur
organizationworld
health
organ
mirlohi
et
al
thu
criteria
use
work
evalu
probiot
bacteria
base
vitro
evalu
function
properti
well
known
behaviour
strain
evalu
condit
analys
function
characterist
ped
pentosaceu
strain
chosen
vivo
trial
mous
model
salmonella
infect
believ
ped
pentosaceu
strain
colon
gut
transient
microorgan
reason
chose
daili
gavag
strain
entir
experiment
period
salmonella
typhimurium
abil
transloc
viscer
organ
mice
caus
system
infect
major
determin
microorgan
pathogen
grassl
et
al
increas
observ
mice
challeng
group
liver
score
expect
hepatomegali
splenomegali
often
report
indic
indirect
bacteri
infect
work
mice
treat
ped
pentosaceu
show
macroscop
chang
liver
base
liver
histolog
score
analys
believ
ped
pentosaceu
alon
safe
synergist
effect
salmonella
pathogenesi
could
includ
increas
gut
permeabl
discuss
studi
also
show
signific
increas
proinflammatori
cytokin
ifnc
throughout
experi
tnfa
day
due
ped
pentosaceu
treatment
indic
proinflammatori
profil
treatment
tnfa
infc
key
mediat
cell
recruit
lesion
induc
activ
recruit
neutrophil
involv
local
inflammatori
process
author
report
regulatori
cytokin
express
profil
found
probiot
bacteria
afford
gastrointestin
diseas
protect
mice
silva
alvim
et
al
other
report
ideal
test
bacteri
strain
induc
express
regulatori
cytokin
tgfb
inflammatori
cytokin
ifnc
contribut
adequ
balanc
two
type
immun
respons
galdeano
perdig
steinberg
et
al
mani
studi
show
probiot
strain
induc
express
proinflammatori
cytokin
ifnc
tnfa
capabl
inhibit
viral
replic
protect
anim
viral
infect
lactobacillu
casei
shirota
strain
protect
influenza
virus
wide
use
ferment
milk
human
consumpt
hori
et
al
tanab
et
al
show
mix
five
hors
probiot
consist
lactobacillu
rumini
lact
equi
lact
reuteri
lactobacillu
johnsonii
bifidobacterium
boum
regul
intestin
function
contribut
diarrhoea
prevent
neonat
thoroughbr
howev
studi
shown
introduct
live
benefici
microorgan
oral
anim
gut
yield
variabl
result
limit
potenti
therapeut
modif
foal
gastrointestin
microbiota
even
advers
effect
note
anim
becom
like
develop
diarrhoea
requir
veterinari
intervent
schoster
et
al
schoster
et
al
data
literatur
also
report
use
lab
induc
inflammatori
respons
immun
adjuv
influenza
polio
rotaviru
cholera
vaccin
paineau
et
al
zhang
et
al
davidson
et
al
equin
strain
ped
pentosaceu
well
four
lab
strain
exhibit
promis
vitro
function
properti
includ
inhibit
acid
moder
inhibit
bile
salt
medium
hydrophob
cellular
surfac
strong
antagon
bacteri
pathogen
nevertheless
show
resist
antimicrobi
intrins
encod
lab
analysi
cytokin
mrna
express
induc
treatment
ped
pentosaceu
reveal
inflammatori
cytokin
pattern
signific
increas
ifnc
tnfa
gene
express
day
inocul
mrna
level
tnfa
ifng
higher
treat
group
control
group
probabl
inflammatori
scenario
intestin
respons
increas
gut
permeabl
consequ
facilit
salmonella
infect
howev
base
data
literatur
possibl
ped
pentosaceu
strain
could
work
adjuv
immun
check
front
protect
import
viral
infect
hors
diarrhoea
foal
caus
rotaviru
coronaviru
respiratori
system
infect
equin
influenza
equin
viral
arthriti
equin
viral
enceph
howev
experiment
mous
infect
salm
typhimurium
previou
treatment
day
ped
pentosaceu
prejudici
anim
acceler
infect
rate
number
death
thu
health
claim
probiot
strain
firstli
establish
vivo
experiment
model
provid
evid
strain
efficaci
precis
label
final
probiot
product
